Firmendatenbank

Category: Biotech Therapeutics & Diagnostics

Eisbach Bio GmbH

Eisbach Bio GmbH

Eisbach Bio develops novel drugs that disrupt molecular machines essential to tumors with defined genetic vulnerabilities in the context of DNA damage and repair (DDR) pathways. Its proprietary platform creates targeted therapies that exploit disease-relevant vulnerabilities. By shutting off the machine’s engine using allosteric inhibitors, their impactful medicines prevent thereorganization and evolution of cancer genomes. Founded in 2019, Eisbach is privately held and backed by international investors.

Am Klopferspitz 19
Deutschland-82152 Martinsried

Firma eintragen

Zum Login


Dr. Andreas Berghammer
Dr. Andreas Berghammer

Community Service Lead